References
- Yilmaz O, Keser S, Tutzcu M, Guvenc M, Cetintas B, Irtegun S et al. A practical HPLC method to measure reduced (GSH) and oxidized (GSSG) glutathione concentrations in animal tissues. J Anim Vet Adv 2009;8:343–347.
- Struzynska L, Chalimoniuk M, Sulkowski G. The role of astroglia in Pb-exposed adult rat brain with respect to glutamate toxicity. Toxicology 2005;212:185–194.
- Sechi G, Deledda MG, Bua G, Satta WM, Deiana GA, Pes GM et al. Reduced intravenous glutathione in the treatment of early Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:1159–1170.
- Leone-Bay A, Paton DR, Weidner JJ. The development of delivery agents that facilitate the oral absorption of macromolecular drugs. Med Res Rev 2000;20:169–186.
- Allenmann E, Lerous J, Gurny R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv Drug Deliv Rev 1998;34:171–189.
- Constantinides PP. Lipid microemulsions for improving drug dissolution and oral absorption:physical and biopharmaceutical aspects. Pharm Res 1995;12:1561–1572.
- Aulton ME. (2002). Pharmaceutics the science of dosage form design. Edinburgh: Churchill Living stone, 334–350.
- Graf A, Rades T, Hook SM. Oral insulin delivery using nanoparticles based on microemulsions with different structure-types:optimisation and in vivo evaluation. Eur J Pharm Sci 2009;37:53–61.
- Cheng MB, Wang JC, Li YH, Liu XY, Zhang X, Chen DW et al. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme. J Control Release 2008;129:41–48.
- Cilek A, Celebi N, Tirnaksiz F. Lecithin-based microemulsion of a peptide for oral administration:preparation, characterization, and physical stability of the formulation. Drug Deliv 2006;13:19–24.
- Raggi MA, Mandrioli R, Casamenti G, Musiani D, Marini M. HPLC determination of glutathione and other thiols in human mononuclear blood cells. Biomed Chromatogr 1998;12:262–266.
- Alany RG, Tucker IG, Davies NM, Rades T. Characterizing colloidal structures of pseudoternary phase diagrams formed by oil/water/amphiphile systems. Drug Dev Ind Pharm 2001;27:31–38.
- Chan J, Maghraby GM, Craig JP, Alany RG. Phase transition water-in-oil microemulsions as ocular drug delivery systems:in vitro and in vivo evaluation. Int J Pharm 2007;328:65–71.
- Martin A, Bustamante P, Chun AHC. (1993). Physical pharmacy. Maryland: Lippincott Williams and Wilkins, 564–565.